Company intelligence / Profile preview
Dr Gerhard Mann
Berlin, Germanybionity.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Dr Gerhard Mann is a long-established German pharmaceutical company specializing in ophthalmology and eye care products. Its portfolio includes both prescription and over-the-counter drugs for various ocular conditions such as infections, dry eye syndrome, and viral diseases of the eye. The company’s marketed products include ganciclovir for cytomegalovirus retinitis and other anti-infective agents like ofloxacin (Floxal). It also produces medical devices such as intraocular lenses and contact lens care solutions.
- Therapeutic areas
- OphthalmologyInfectious Diseases
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Dr Gerhard Mann.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dr Gerhard Mann.